Elevation of Serum Pro-Gastrin - Releasing Peptide in Patients with Medullary Thyroid Carcinoma and Small Cell Lung Carcinoma-Reference-Cited by-同舟云学术

Elevation of Serum Pro-Gastrin - Releasing Peptide in Patients with Medullary Thyroid Carcinoma and Small Cell Lung Carcinoma

Published:2001-11 Issue:11 Volume:11 Page:1055-1061
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Ide Akane¹,Ashizawa Kiyoto¹,Ishikawa Naofumi²,Ishii Reiko¹,Ando Takao¹,Abe Yasuyo¹,Sera Nobuko¹,Usa Toshiro¹,Tominaga Tan¹,Ejima Eri¹,Nakashima Masahiro³,Ito Kouichi²,Ito Kunihiko²,Eguchi Katsumi¹

Affiliation:

1. First Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan

2. Ito Hospital, Tokyo, Japan

3. Tissue and Histopathology Section, Division of Scientific Data Registry, Atomic Bomb Disease Institute, Nagasaki University of Medicine, Nagasaki, Japan

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/105072501753271752

Reference26 articles.

1. Total thyroidectomy for occult familial medullary carcinoma of the thyroid in children

2. Pathological and clinical findings in a series of 67 cases of medullary carcinoma of the thyroid

3. Analysis of thyroid carcinoma based on material registered in japan during 1977-1 986 with special reference to predominance of papillary type

4. Changing Concepts in the Management of Hereditary and Sporadic Medullary Thyroid Carcinoma

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progastrin-Releasing Peptide As a Diagnostic Biomarker of Pulmonary and Non-Pulmonary Neuroendocrine Neoplasms;Endocrine Research;2024-07-23

2. Exploring the application value of pro‐gastrin‐releasing peptide in the clinical diagnosis and surgical treatment of medullary thyroid carcinoma;Cancer Medicine;2023-09-27

3. Other markers of medullary thyroid cancer, not only calcitonin;European Journal of Endocrinology;2023-01-01

4. Utilizing the circulating tumor markers in diagnosis and management of medullary thyroid cancer;Pathology - Research and Practice;2022-01

5. Circulating pro-gastrin releasing peptide (ProGRP) in patients with medullary thyroid carcinoma;Clinical Chemistry and Laboratory Medicine (CCLM);2021-04-16